Trial Profile
A Phase I Trial to Evaluate the Safety and Immunogenicity of a ChAdOx1 85A Vaccination with and without MVA85A Boost in Healthy BCG Vaccinated Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs ChAdOx1 85A (Primary) ; MVA 85A (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; First in man
- 14 Nov 2019 Results assessing safety by collection of solicited and unsolicited vaccine related adverse events and Immunogenic responses were published in the Vaccine
- 10 May 2016 Status changed from active, no longer recruiting to completed.
- 18 Aug 2015 Accrual to date is 100% according to United Kingdom Clinical Research Network record.